SA Pharmaceutical Journal - Volume 82, Issue 6, 2015
Volume 82, Issue 6, 2015
"It's all about doing the right thing, in the right way, at the right time and for the right reason" : president's messageAuthor Sarel MalanSource: SA Pharmaceutical Journal 82 (2015)More Less
It is an honour and a privilege to be elected as president of our professional Society, undeniably the pinnacle in my professional career. Thank you for putting your trust in me. I will, in all I do, endeavour to deliver on that trust. Thank you to everyone who has supported and whose interaction has formed and shaped me during the years leading to this point; the previous leaders of the Society who have taught me many things over the years; the Academy of Pharmaceutical Sciences for providing the learning environment and growth opportunities; the North-West and Cape Western Province branches where I was blessed with wise men and women to advise me; my wife and family who have always stood by me and accepted the role of my career and profession in my life.
Source: SA Pharmaceutical Journal 82 (2015)More Less
The mission of the Young Pharmacists' Group is to promote the goals of PSSA by encouraging the young members of the Society to participate in PSSA projects and activities. In so doing, YPG aims to develop individuals who can act as agents of positive change at local, national and international levels, both in the profession and in their society.
Author Haley Van WykSource: SA Pharmaceutical Journal 82, pp 14 –18 (2015)More Less
Many people use the terms "heartburn" and "indigestion" interchangeably. These digestive problems are often confused, and although they both have similar triggers and symptoms, and the treatment may be the same in many instances, indigestion is not heartburn. It is important to distinguish between the two in order to manage them appropriately.
Author Sonal PatelSource: SA Pharmaceutical Journal 82, pp 20 –23 (2015)More Less
Hepatitis is inflammation of the liver. The degree of severity of hepatitis varies from acute self-limiting to severe chronic cases involving fibrosis, cirrhosis, hepatocellular carcinoma or liver failure. Hepatitis occurs due to infection, the use of toxic substances, e.g. alcohol and drugs, and autoimmune disease. However, viral hepatitis infection is the most common cause. Five main types of viral hepatitis have been identified, namely hepatitis A, hepatitis B, hepatitis C, hepatitis D and hepatitis E viruses. The transmission of hepatitis A and E primarily occurs through the faecal-oral route, whereas the transmission of hepatitis B, C and D is due to contact with infected blood and bodily fluids. This review focuses on the route of transmission, symptoms, diagnosis, and the treatment and prevention options for the five main types of hepatitis viral infection. Immunisation plays a significant role in the prevention of certain types of viral hepatitis. Available vaccines are highlighted. Pharmacists can use this information to educate patients and reduce the incidence and mortalities associated with hepatitis, particularly viral hepatitis.
Source: SA Pharmaceutical Journal 82, pp 24 –29 (2015)More Less
Chronic obstructive pulmonary disease (COPD) is a leading cause of death worldwide. It is a chronic condition that affects the respiratory system and worsens over time. The two major risks that are associated with this disease are cigarette smoking and an advancing age. It is concerning that the global incidence of this chronic illness is on the rise, with current projections indicating that it will become the third-leading cause of death by the year 2020. Inflammatory changes underlie the pathophysiology of COPD, with irreversible damageand a progressive narrowing of the air passages that follow. COPD is characterised by a progressive loss of lung function. In addition,the Global Strategy for the Diagnosis, Management, and Disease Prevention of Chronic Obstructive Pulmonary Disease, or GOLD,released the latest update of their Global Strategy for the Diagnosis, Management, and prevention of Chronic Obstructive PulmonaryDisease in 2015. This article provides an overview of the causative risk factors, the underlying disease process and pathophysiologicalchanges, the classification and the management of COPD, including the latest perspectives on this highly-prevalent condition.
Author Gail MkeleSource: SA Pharmaceutical Journal 82, pp 30 –32 (2015)More Less
The pharmacy is often the first port of call for patients with a dermatological disorder. The percentage of people who consult pharmacies in connection with skin conditions is unknown. However, anecdotal evidence suggests that a large number of minor skin complaints are routinely seen in community pharmacies. These conditions may be bacterial, fungal, viral, parasitical or allergic in nature. When considering skin complaints, it is important to distinguish between diseases of the skin itself, systemic diseases with a cutaneous manifestation, as well as cutaneous adverse drug reactions. Of the many skin conditions with which patients present at a pharmacy, only a few will be considered, with a focus on their aetiology, clinical features and treatment options.
Author Jacky Van SchoorSource: SA Pharmaceutical Journal 82, pp 33 –36 (2015)More Less
Several options are available to treat moderate to severe vasomotor symptoms in menopausal women, including oestrogen-only and oestrogen-progestogen combination products, to meet the needs of both hysterectomised and non-hysterectomised women, respectively. In addition to selecting an appropriate oestrogen or oestrogen-progestogen combination, consideration should be given to the route of administration to best suit the needs of the individual patient. Delivery systems for menopausal hormone therapy include oral tablets, transdermal patches, transdermal gel and intravaginal preparations. While oral therapy remains the most commonly used route of administration in many countries, evidence suggests that oral delivery may lead to some undesirable physiological effects as a result of significant gut and hepatic first-pass metabolism of oestrogen. Advantages of the transdermal route include the ability to administer oestradiol (the exact molecular form of oestrogen secreted by the premenopausal ovary) directly to the bloodstream using a lower dose than oral oestrogen, and causing minimal stimulation of hepatic protein production. This review article compares the risks and benefits of oral versus transdermal hormone therapy for the treatment of menopausal symptoms.
Source: SA Pharmaceutical Journal 82, pp 37 –38 (2015)More Less
Obligatory Pharmacy Council inspections : your professional integrity assured : pharmaceutical practitionerAuthor Jan Du ToitSource: SA Pharmaceutical Journal 82, pp 44 –46 (2015)More Less
This month's topic was the title for the first Sector Workshop held by the CPS Southern Gauteng Branch for 2015. The workshop was designed to assist pharmacists and pharmacist's assistants to understand the importance of Pharmacy Council inspections and the benefits that accrue from being well prepared for them.
Author Gary S. BlackSource: SA Pharmaceutical Journal 82, pp 47 –50 (2015)More Less
The Code of Ethics for pharmacists requires them to observe, respect and protect the confidentiality of any information acquired in the course of providing professional services. This undertaking of confidentiality is enshrined in the following clause of the Pharmacist's Oath: "Not to divulge improperly any personal or confidential matter, directly or indirectly, confided to me by my patients or clients, even after death".